101P: European results from the 2024 International Association for the Study of Lung Cancer (IASLC) global survey on biomarker testing
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Thoracic Oncology
Authors: M.P. Smeltzer, C. Connolly, K. Brunson, M. Chau, S. Chen, A. Kerpel, S. Lantuejoul, A. Mohan, A. Plaxco, J. Rice, U. Basu Roy, R. Santos, R.A. Soo, G. Woodard, M. Wynes, Y. Yatabe, J. King, K. Kelly
Institutions: University of Memphis, International Association for the Study of Lung Cancer, Roche (United States), Genentech, AstraZeneca (United States), Országos Korányi Tbc és Pulmonológiai Intézet, Centre Léon Bérard, All India Institute of Medical Sciences, LUNGevity Foundation, Serviço Nacional de Aprendizagem Industrial, Universidade SENAI CIMATEC, National University Cancer Institute, Singapore, Yale University, National Cancer Center Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4408979344